TMCI:NASDAQ
Treace Medical Concepts, Inc
US$ ४.५६
arrow_downward
-०.४४%(-०.०२०) 1D
US$ ४.५६
०.००% (०.००)
bedtimeAfter hours
Closed: सेप्टेम्बर १६, १६:००:०० GMT-४ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
US$ ४.५७
High
US$ ४.६२
Low
US$ ४.४९
Mkt. cap
२९.६६ करोड
Avg. vol.
३.४९ लाख
Volume
१.६६ लाख
52-wk high
US$ ७.६१
52-wk low
US$ १.१७
EPS
-US$ ०.९३
Beta
१.४१
Shares outstanding
६.५० करोड
No. of employees
४५०
Open
US$ ४.५७
High
US$ ४.६२
Low
US$ ४.४९
Mkt. cap
२९.६६ करोड
Avg. vol.
३.४९ लाख
Volume
१.६६ लाख
52-wk high
US$ ७.६१
52-wk low
US$ १.१७
EPS
-US$ ०.९३
Beta
१.४१
Shares outstanding
६.५० करोड
No. of employees
४५०
News stories
From web sources and news partners
Stock Titan
·
१ दिन पहिले
New bunion tools and five-year study results will be shown in Seattle
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc